Five notes:
1. Fourth-quarter revenue was $15.4 million, an 8 percent decrease year over year. Full-year revenue was $99.9 million, up 45 percent compared with 2020.
2. Conformis’ hip system saw gains in fourth-quarter and full-year sales. In the fourth quarter, it had an 8 percent increase in year-over-year sales. In all of 2021, Conformis’ hip system saw $3 million in sales, up 19 percent from 2020.
3. Overall product sales decreased 8 percent year over year in the fourth quarter at $15.3 million. Full-year product revenue in 2021 remained flat compared to 2020.
4. In the fourth quarter, Conformis finalized the commercial launch of its image-to-implant service program.
5. Conformis forecasts $13.5 million to $14.5 million in sales in the first quarter of 2022.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
